This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences Pla China. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Shengqian Yang: Innovator in c-Fms Kinase Inhibitors
Introduction
Shengqian Yang is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmacology, particularly in the development of methods for screening c-Fms kinase inhibitors. His work is essential for advancing therapeutic options in various medical conditions.
Latest Patents
Shengqian Yang holds a patent for a "Cell model and method for screening c-Fms kinase inhibitors." This invention provides a cell model that expresses macrophage colony stimulating factor receptor and STAT1 protein simultaneously. The method developed allows for the screening of c-Fms tyrosine kinase inhibitors, evaluating the inhibiting activity of compounds against c-Fms tyrosine kinase. The established cell model is noted for its sensitivity, effectiveness, and reliability, making it suitable for high-throughput and high-content screening of c-Fms tyrosine kinase inhibitors. He has 1 patent to his name.
Career Highlights
Shengqian Yang is affiliated with the Institute of Pharmacology and Toxicology at the Academy of Military Medical Sciences in China. His role at this prestigious institution allows him to engage in cutting-edge research and innovation in pharmacology.
Collaborations
He has collaborated with notable colleagues, including Lili Wang and Long Long, contributing to the advancement of research in his field.
Conclusion
Shengqian Yang's innovative work in developing a cell model for screening c-Fms kinase inhibitors highlights his significant contributions to pharmacology. His research is paving the way for new therapeutic strategies in medicine.